|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘 | Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford | 2010 | The Lancet2010，，9742： | 3 |
| 2 | Boceprevir for untreated chronic HCV genotype 1 infection显示文摘 | Poo~ad F Bacon BR | 2011 | N Engl J Med2011，364，13： | 1 |
| 3 | Boceprevir for untreated chronic HCV genotype 1 infection 显示文摘 | Poordad F McCone J Jr Bacon BR | 2011 | N Engl J Med2011，364，13： | 1 |
| 4 | HCV SPRINT-1 final results: SVR 24 from a phase 2 study of boceprevir plus PeglFN alpha-2b/ribavirin in treatment-naive subjects with genotype 1 chronic hepatitis显示文摘 | Kwo P Lawitz E J McCone J | 2009 | J Hepatol2009，50，1： | 1 |
| 5 | Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection 显示文摘 | McHutchison JG Lawitz FJ Shiffman ML Muir AJ Galler GW McCone J Nyberg LM Lee WM Ghalib RH Schiff ER Galati JS Bacon BR Davis MN Mukhopadhyay P Koury K Noviello S Pedicone LD Brass CA Albrecht JK Sulkowski MS IDEAL Study Team | 2009 | N Engl J Med2009，361，6： | 1 |
| 6 | Boeeprevir for untreated chronic HCV genotype 1 infection显示文摘 | Poordad F McCone Jr J Bacon B R et d | 2011 | N EnglJ Ned2011，364，11： | 1 |
| 7 | Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘 | Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford | 2010 | The Lancet2010，，9742： | 1 |
| 8 | Boceprevlr for Untreated Chronic HCV Genotype 1 Infection显示文摘 | Poordad F McCone J Jr Bacon BR | | New England Journal of Medicine0，，： | 1 |
| 9 | HCV SPRINT-1 final results:SVR 24 from a phase 2 study of boceprevir plus Peglntron? (peginterferon alfa-2b)/ribavirin in treatment-naive subjects with genotype 1 chronic hepatitis C显示文摘 | Kwo P Lawitz E McCone J | | Journal of Hepatology0，，： | 1 |
| 10 | Boceprevir for untreated chronic HCV genotype 1 infection 显示文摘 | Poordad F McCone J Jr Bacon BR Bruno S Manns MP Sulkowski MS Jacobson IM Reddy KR Goodman ZD Boparai N DiNubile MJ Sniukiene V Brass CA Albrecht JK Bronowicki JP SPRINT-2 Investigators | 2011 | N Engl J Med2011，364，13： | 1 |
| 11 | Interim results from HCV SPRINT-1:RVR/EVR from phase 2 study of boceprovir plus pegintron (peginteferon alfa-2b)/ribavirin in treatment-naive subjects with HCV genotype 1 CHC显示文摘 | Kwo P Lawitz E McCone J | 2008 | J Hepatol2008，48，2： | 1 |
| 12 | Impact of weight -based ribavirin with peginteferon alfa -2b in African Americans with hepatitis C virus genotype 1 显示文摘 | Jacobson IM Brown RS Jr McCone J | 2007 | Hepatology2007，46，4： | 1 |
| 13 | Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘 | Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford | 2010 | The Lancet2010，，9742： | 1 |
| 14 | Boceprevir for untreated chronic HCV genotype 1 infection 显示文摘 | Poordad F McCone J Jr Bacon BR | 2011 | N Engl J Med2011，364，13： | 1 |
| 15 | Boceprevir for untreated chronic HCV genotype 1 infection 显示文摘 | Poordad F Mccone J Jr Bacon BR | 2011 | N Engl J Med2011，364，13： | 1 |
| 16 | HCV SPRINT-l: bo- ceprevir plus peginterferon alfa-2b/ribavirin for treatment of genotype 1 chronic hepatitis C in previously untreated pa- tients 显示文摘 | Kwo P Lawitz E McCone J | 2008 | Hepatology2008，48，41： | 1 |
| 17 | HCV SPRINT-1 final re- suits: SVR 24 from a phase 2 study of boceprevir plus PegIntron (peginterferon alfa-2b)/ribavirin in treat- ment-naive subjects with genotype 1 chronic hepatitis C 显示文摘 | Kwo P Lawitz E McCone J | | J Hepatol0，50，1： | 1 |
| 18 | Boceprevir for untreated chronic HCV genotype 1 infection显示文摘 | Poordad F McCone J Jr Bacon BR | 2011 | N Engl J Med2011，364，13： | 1 |
| 19 | Boceprevir for Untreated Chronic HCV Genotype 1 Infection 显示文摘 | Poordad F McCone J Jr Bacon BR | 2011 | NEJM2011，364，13： | 1 |
| 20 | HCV SPRINT-1 final resuits: SVR 24 from a phase 2 study of boceprevir plus pegintron^TM (peginterferon alfa-2b ) / ribavirin in treatment-naive subjects with genotype 1 chronic hepatitis C显示文摘 | Kwo P Lawitz E McCone J | 2009 | J Hepatol2009，50，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员